本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

IceCure Medical Ltd.

1.21
+0.01621.36%
成交量:5.25万
成交额:6.33万
市值:6,823.35万
市盈率:-4.01
高:1.24
开:1.19
低:1.18
收:1.19
数据加载中...
2025/03/27

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2025/03/27

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/08

[修订]招股说明书

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2024/11/05

[修订]招股说明书

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2024/10/15

招股说明书

Form F-1 - Registration statement for certain foreign private issuers
2024/08/16

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/04/03

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/01/11

SEC问询函

Form CORRESP - Correspondence
2023/10/14

SEC问询函

Form CORRESP - Correspondence
2023/03/30

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2023/03/29

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/01/24

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/09/12

SEC问询函

CORRESP [Cover] - Correspondence
2022/08/22

[修订]年度报告

20-F/A [Amend] - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/04/29

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2022/04/01

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/02/28

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/23

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals